Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Cerezyme
Active Ingredient: Imiglucerase-rch 212U
Dosage Form: Powder for infusion
New Zealand Sponsor: Medra Services Limited
Manufacturer: Genzyme Corporation, Allston, Massachusetts, United States of America
Note: This consent is valid for 2 years from 29 July 2005.
Dated this 14th day of July 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).